How long does one box of Pemetinib last? How to calculate the dosage cycle and course of treatment?

Pemigatinib (Pemigatinib) is an FGFR (fibroblast growth factor receptor) inhibitor, mainly used to treat cholangiocarcinoma carrying FGFR2 fusion or rearrangement mutations, as well as certain types of bladder cancer. The dosage cycle and course of treatment need to be determined according to the specific indications and individual patient conditions.

First of all, the standard recommended dose of pemetinib is 13.5 mg once a day for 14 consecutive days, and then stopped for 7 days to complete a 21-day treatment cycle. This cycle pattern (14days of medication+7days of rest) can help reduce the cumulative toxicity of the drug and improve tolerance. Therefore, the length of time a box of pemetinib should be taken depends on the package size and the patient's daily dose.

If calculated based on the specification of 14 tablets per box, under standard usage, each box can last for approximately 14 days, which completes the medication phase of a 21 day treatment course. Patients need to continue taking the treatment until the disease progresses or the side effects are intolerable. Doctors will adjust the treatment plan based on efficacy and side effects, and some patients may need dose adjustment or discontinuation of medication for observation.

In addition, the duration of pemetinib treatment varies among individuals and usually lasts for several months or even longer. Patients need to regularly monitor liver function, electrolyte levels and eye health during treatment, as it may cause side effects such as hyperphosphatemia and retinopathy. Following the doctor's guidance and reasonably arranging the medication cycle will help improve the therapeutic effect and reduce the impact of adverse reactions.

Reference materials:https://go.drugbank.com/drugs/DB15102